Atom Investors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.35M Sell
317,596
-82,964
-21% -$1.14M 0.39% 63
2025
Q1
$4.43M Buy
400,560
+254,828
+175% +$2.82M 0.55% 49
2024
Q4
$1.55M Buy
+145,732
New +$1.55M 0.19% 154
2024
Q3
Sell
-144,780
Closed -$2.43M 614
2024
Q2
$2.43M Buy
144,780
+94,990
+191% +$1.59M 0.24% 132
2024
Q1
$747K Sell
49,790
-10,375
-17% -$156K 0.09% 261
2023
Q4
$902K Buy
60,165
+44,505
+284% +$668K 0.16% 198
2023
Q3
$219K Buy
+15,660
New +$219K 0.05% 366
2019
Q3
Sell
-62,863
Closed -$2.26M 426
2019
Q2
$2.26M Buy
+62,863
New +$2.26M 0.15% 174